12 Small Cap Stocks with High Upside Potential
The trade war saga between the U.S. and China appears to be nearing a conclusion, as China’s Ministry of Commerce shared details on the trade deal on June 27.
Collegium Pharmaceutical Inc (COLL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 3,000,000 | $89,550,000 | +28% | 1.6% |
| 2. | Renaissance Technologies Jim Simons | 1,616,049 | $48,239,063 | -3% | 0.07% |
| 3. | 33,200,000 | $35,669,250 | -12% | 0.92% | |
| 4. | Millennium Management Israel Englander | 647,832 | $19,337,785 | +249% | 0.01% |
| 5. | Citadel Investment Group Ken Griffin | 510,155 | $15,228,127 | +45% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.18 | 10,000 | $91,800.00 | 110,227 | 2017-05-12 | Filing | |
| $10.59 | 2,375 | $25,151.25 | 2,375 | 2016-08-12 | Filing | |
| $12.00 | 3,930 | $47,160.00 | 65,270 | 2015-05-12 | Filing | |
| $12.00 | 196,070 | $2,352,840.00 | 3,256,572 | 2015-05-12 | Filing | |
| $12.00 | 150,000 | $1,800,000.00 | 1,887,332 | 2015-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.62 | 6,601 | $202,149.02 | 70,658 | 2025-06-09 | Filing | |
| $30.03 | 6,396 | $192,068.68 | 156,667 | 2025-03-21 | Filing | |
| $30.00 | 1,206 | $36,181.33 | 163,063 | 2025-03-20 | Filing | |
| $30.03 | 18,881 | $566,983.21 | 103,613 | 2025-03-21 | Filing | |
| $30.00 | 1,927 | $57,810.96 | 122,494 | 2025-03-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,976 | $708,970 | 0.11% | |
| 2. | 1,550 | $45,834 | 0.01% | |
| 3. | 448 | $13,247 | 0% | |
| 4. | 290 | $8,575 | 0% | |
| 5. | 17,884 | $529 | 0.02% |
News See All
Collegium Pharmaceutical Announces Share Repurchase Program Worth $25 Million
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is one of the 12 Small Cap Stocks with High Upside Potential.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2025 Earnings Call Transcript
Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded.
12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Collegium Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Collegium Pharmaceutical Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Collegium Pharmaceutical Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
The major index futures are slightly in the red this morning.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Earnings Call Transcript
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Earnings Call Transcript May 9, 2024Collegium Pharmaceutical, Inc. misses on earnings expectations.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Billionaire Hedge Funds
